Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2011-06-10 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2011
Transaction in Own Shares Classification · 99% confidence The document text details specific transactions related to Novozymes' share buyback program ('aktietilbagekøbsprogram') conducted under the 'Safe Harbour' regulation. It reports the number of shares bought back, the average purchase price, and the total value of these transactions over several days in June 2011. It also reports the resulting number of treasury shares held. This content directly relates to the company repurchasing or dealing in its own shares. Therefore, the most appropriate classification is Transaction in Own Shares (POS). The document length is relatively short (2654 chars), but it is a detailed report of transactions, not just an announcement that a report is available (which would suggest RPA or RNS).
2011-06-10 English
Director's Dealing 2011
Director's Dealing
2011-06-03 Danish
Transaction in Own Shares 2011
Transaction in Own Shares Classification · 99% confidence The document explicitly details transactions made under a share buyback program initiated on February 11, 2011, referencing the European Commission's Safe Harbour Regulation. It provides tables showing the number of shares bought back and the transaction value over specific dates (May 27 to June 02, 2011). This content directly relates to the company repurchasing its own shares. According to the definitions, 'Transaction in Own Shares (Code: POS)' covers 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. The document is a report of these transactions, not just an announcement of a report.
2011-06-03 English
Director's Dealing 2011
Director's Dealing
2011-06-03 Danish
Transaction in Own Shares 2011
Transaction in Own Shares Classification · 99% confidence The document text details specific transactions related to Novozymes' share buyback program ('aktietilbagekøbsprogram') executed under the 'Safe Harbour' regulation. It reports the number of shares bought back, the average purchase price, and the total value of these transactions over a specific period (May 27 to June 2, 2011). It also updates the total number of treasury shares held. This content directly relates to the company repurchasing or dealing in its own shares. Therefore, the most appropriate classification is Transaction in Own Shares (POS). The document length is short (2778 chars), but it is a detailed report of transactions, not just an announcement that a report is available, thus distinguishing it from RPA or RNS.
2011-06-03 English
Regulatory Filings 2011
Regulatory Filings
2011-06-01 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.